Skip to content
Medical Health Aged Care

REGIONAL AUSTRALIANS BEARING THE BRUNT OF THE OBESITY CRISIS

McKell Institute & Menzies Research Centre 2 mins read

A new national report has found Australians living in regional communities are disproportionately affected by the country’s obesity epidemic, highlighting a growing health and economic gap between the city and country.

The report, A Preventable Crisis, released by the McKell Institute and the Menzies Research Centre, shows two in three Australian adults are now overweight or obese, while one in four children aged 5 to 17 falls into the same category.

Regional communities are particularly exposed to the impacts of rising obesity rates due to differences in healthcare access, food availability and socioeconomic conditions.

“Obesity disproportionately affects socioeconomically disadvantaged groups and rural and regional populations, reinforcing health inequities,” the report says.

The research found children from lower-income households are nearly twice as likely to experience obesity as those in higher-income households, reflecting the broader link between health outcomes and economic disadvantage.

McKell Institute Chief Executive Officer Edward Cavanough said: “Australians living outside the major cities are often facing higher health risks while having fewer services available to help manage those risks. Addressing obesity is not just about individual behaviour - it requires policy responses that recognise the different challenges facing regional communities.”

The report estimates obesity already costs the Australian economy more than $39 billion a year, with more than 60 per cent of that burden driven by lost productivity, including time off work and reduced workforce participation.

Menzies Research Centre Executive Director David Hughes said: “When obesity leads to poorer health and reduced workforce participation, regional communities can feel those effects very quickly. This is not just a health issue - it also affects productivity, economic opportunity and long-term prosperity.”

Despite the growing scale of the problem, Australia currently spends around 2 per cent of its health budget on prevention, significantly below the OECD average of 3–4 per cent.

The economic cost of obesity is projected to reach $87.7 billion annually by 2032 and $228 billion by 2060, with more than 60 per cent of the costs linked to lost productivity, including absenteeism, reduced workplace performance and premature death.

Its contribution to diseases such as type 2 diabetes, cardiovascular disease and at least 13 cancers makes obesity and overweight conditions responsible for 8.3 per cent of Australia’s total disease burden and the largest single driver of preventable health loss, the report says.

The report recommends a coordinated national approach combining prevention, improved treatment pathways and stronger policy leadership. It also calls for measures including mandatory Health Star Ratings on packaged foods, incentives for workplace health programs and increased investment in preventive health initiatives.

The report, commissioned by Novo Nordisk, marks the first time the progressive McKell Institute and conservative Menzies Research Centre have worked together on a major research project. The report is available here.


Contact details:

Ben Mitchell: 0419 850 212

Media

More from this category

  • Medical Health Aged Care
  • 16/06/2026
  • 22:47
Optimi Health Corp.

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research

Two naturally derived finished drug products, at 1mg and 2mg, give research organizations the consistent, validated doses required for controlled studiesNew microdose formats extend Optimi's psilocybin range, which includes a 5mg formulation currently commercially prescribed for treatment-resistant depression in Australia under the country's Authorized Prescriber SchemeVANCOUVER, British Columbia, June 16, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage GMP pharmaceutical manufacturer of regulated psychedelic drug products, today announced it has completed production of two microdose psilocybin finished drug products, formulated at 1 mg and 2 mg dosages. The products…

  • Medical Health Aged Care
  • 16/06/2026
  • 14:30
Dementia Australia

Brisbane comes together for people impacted by dementia

Brisbane community members tied up their laces and showed up in force last weekend for the 2026 Brisbane Memory Walk & Jog - throwing their support behind people impacted by dementia whilst getting active to improve their brain health. More than 1,470 people walked, ran and jogged to the finish line to raise an impressive total of $195,098. Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, volunteered and raised vital funds for the cause. “There was an incredible turnout from the Brisbane community this year yet again, in support of the many people impacted by…

  • Contains:
  • Biotechnology, Medical Health Aged Care
  • 16/06/2026
  • 09:51
ENA Respiratory

ENA Respiratory Receives USPTO Notice of Allowance for Two Patents Covering TLR2 Agonists and Rhinovirus-Mediated COPD Exacerbations

Melbourne, Australia, 15 June 2026 – ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated with respiratory viral infections in at-risk populations, announces today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for two patent applications notably a composition-of-matter patent and method-of-use for its Toll-like receptor 2 (TLR2) therapies. A composition-of-matter patent (US 17/622,451, "A series of TLR2 agonist compounds") and A method-of-use patent for the treatment of rhinovirus-mediated exacerbations of chronic obstructive pulmonary disease (COPD) (US 16/495,829, "Methods of treating rhinovirus-mediated exacerbations of COPD…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.